Abstract:Objective: Both oncogenic transcription factors (TFs) and microRNAs (miRNAs) play an important regulator in human cancer by transcriptional and post-transcriptional regulation, respectively. These phenomena raise questions about the ability of artificial device to regulate miRNAs and TFs simultaneously. In this study, we aimed to construct an artificial long non-coding RNA, “alncRNA,” which imitated CRISPR/Cas systems and to illuminate its therapeutic effects in bladder cancer cell lines. At the same time, we also compared the efficiency of alncRNA and CRISPR/Cas systems in regulating gene expression. Study Design and Methods: Based on engineering principles of synthetic biology, we combined tandem arrayed cDNA sequences of aptamer for TFs with tandem arrayed cDNA copies of binding sites for the miRNAs to construct alncRNA. In order to prove the utility of this platform, we chose β -catenin, NF-κB, miR-940, and miR-495 as the functional targets and used the bladder cancer cell lines 5637 and T24 as the test models. Real-time Quantitative PCR (qPCR), dual-luciferase assay and relative phenotypic experiments were applied to severally test the expression of relative gene and therapeutic effects of our devices. Result: Dual-luciferase assay indicated alncRNA could inhibit transcriptional activity of TFs. What’s more, the result of qPCR showed that expression levels of the relative TFs target genes and miRNAs were reduced by corresponding alncRNA and the inhibitory effect was better than CRIPSR dCas9-KRAB. By functional experiments, decreased cell proliferation, increased apoptosis, and motility inhibition were observed in alncRNA-infected bladder cells. Conclusion: In summary, our synthetic devices indeed function as anti-tumor regulator, which synchronously accomplish transcriptional and post-transcriptional regulation in bladder cancer cell and show higher efficiency in specific malignant phenotype inhibition compared to the CRISPR/Cas systems. Most importantly, Anti-cancer effects were induced by the synthetic alncRNA in the bladder cancer lines. Our devices, therefore, provides a novel strategy for cancer therapy and could be a useful “weapon” for cancer cell.

Synthetic miRNA-mowers targeting miR-183-96-182 cluster or miR-210 inhibit growth and migration and induce apoptosis in bladder cancer cells.

Synthetic Mirna Sponges Driven by Mutant Htert Promoter Selectively Inhibit the Progression of Bladder Cancer

Synthetic artificial microRNAs targeting UCA1-MALAT1 or c-Myc inhibit malignant phenotypes of bladder cancer cells T24 and 5637.

Synthetic Tet-inducible Artificial Micrornas Targeting Β-Catenin or HIF-1α Inhibit Malignant Phenotypes of Bladder Cancer Cells T24 and 5637

Synthetic Artificial "long Non-Coding RNAs" Targeting Oncogenic Micrornas and Transcriptional Factors Inhibit Malignant Phenotypes of Bladder Cancer Cells

Nonconserved Mir‐608 Suppresses Prostate Cancer Progression Through RAC2/PAK4/LIMK1 and BCL2L1/caspase‐3 Pathways by Targeting the 3′‐utrs of RAC2/BCL2L1 and the Coding Region of PAK4

Synthetic Circular Multi-Mir Sponge Simultaneously Inhibits Mir-21 and Mir-93 in Esophageal Carcinoma

Synthetic Regulatory RNAs Selectively Suppress the Progression of Bladder Cancer

Mir-1307-5p Suppresses Proliferation and Tumorigenesis of Bladder Cancer Via Targeting MDM4 and the Hippo Signaling Pathway

Synthetic Tet-inducible Small Hairpin RNAs Targeting Htert or Bcl-2 Inhibit Malignant Phenotypes of Bladder Cancer T24 and 5637 Cells

Mir-135a Enhances Cellular Proliferation Through Post-Transcriptionally Regulating PHLPP2 and FOXO1 in Human Bladder Cancer

Up-regulation of P21(waf1/cip1) by Mirnas and Its Implications in Bladder Cancer Cells.

AB112. Constructing Several Amirnas with Multiple Targets to Silence Selectively Cancer Gene and to Inhibit the Growth of Bladder Cancer Cells

Synthetic Artificial Long Non-coding RNA Shows Higher Efficiency in Specific Malignant Phenotype Inhibition Compared to the CRISPR/Cas Systems

Synthetic Circular RNA Functions As a Mir-21 Sponge to Suppress Gastric Carcinoma Cell Proliferation.

CCND1, NOP14 and DNMT3B Are Involved in Mir‐502‐5p–mediated Inhibition of Cell Migration and Proliferation in Bladder Cancer

Mir-451 Inhibits Invasion and Proliferation of Bladder Cancer by Regulating EMT.

Small RNA Zippers Lock Mirna Molecules and Block Mirna Function in Mammalian Cells.

Inducing Cell Proliferation Inhibition and Apoptosis Via Silencing Dicer, Drosha, and Exportin 5 in Urothelial Carcinoma of the Bladder

MicroRNA-320c Inhibits Tumorous Behaviors of Bladder Cancer by Targeting Cyclin-dependent Kinase 6

MicroRNA-3619-5p suppresses bladder carcinoma progression by directly targeting β-catenin and CDK2 and activating p21